NCT03988907View on ClinicalTrials.gov

A Drug-drug Interaction Study With Risdiplam Multiple Dose and Midazolam in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

September 29, 2019

Study Completion Date

September 29, 2019

Conditions
Spinal Muscular Atrophy
Interventions
DRUG

Risdiplam

Part 1: a dose of 5 milligram (mg) risdiplam QD ; Part 2: precise dose will be based on Part 1 results

DRUG

Midazolam

single dose administration of 2 mg midazolam

Trial Locations (1)

75247

Covance Research Unit - Dallas, Dallas

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT03988907 - A Drug-drug Interaction Study With Risdiplam Multiple Dose and Midazolam in Healthy Participants | Biotech Hunter | Biotech Hunter